/
Company Overview We, through our wholly owned subsidiary Skinvisible Pharmaceuticals Inc., are a pharmaceutical research and development ( R&D ) company that has developed and patented an innovative polymer delivery system, Invisicare and formulated over forty topical skin products, which we out-license globally. We were incorporated in 1998 and target an estimated $80 billion global skincare a…
The business is unprofitable at the operating level (-2481.58% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 0.0% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$42K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$20K
Net Income (TTM)
-$1M
▼ -88.1% YoY
Op. Margin
-2412.01%
▲ +466.4pp YoY
ROIC
-108.24%
▲ +126.2pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$42K
▲ +46.2% YoY
Op. Cash Flow (TTM)
-$8K
▲ +45.0% YoY
Net Debt
$350K
Cash & Equiv.
$2K
5Y CAGR: -33.4%
Continue Research